Wai Jin Tan

Title: Innovations in Breast Tumor Diagnosis by Wai Jin Tan

Introduction

Wai Jin Tan is a notable inventor based in Singapore, recognized for his contributions to medical diagnostics. He has developed a significant patent that enhances the understanding and treatment of fibroepithelial tumors of the breast. His work is pivotal in the field of oncology, particularly in the accurate classification of breast tumors.

Latest Patents

Wai Jin Tan holds a patent for a multigene assay that provides an in vitro method for determining the type of fibroepithelial tumor in a biological sample. This innovative method involves obtaining an expression profile of various genes and determining their differential activity relative to a control. The results yield a p-score that helps classify the tumor type, distinguishing between fibroadenoma and phyllodes tumor. The method is exemplified using an expression profile of five specific genes, showcasing its practical application in clinical settings.

Career Highlights

Wai Jin Tan is associated with Lucence Life Sciences Pte Ltd., where he applies his expertise in molecular diagnostics. His work at Lucence focuses on advancing cancer detection technologies, contributing to improved patient outcomes through innovative diagnostic solutions.

Collaborations

Wai Jin Tan collaborates with talented professionals in his field, including Min-Han Tan and Puay Hoon Tan. These collaborations enhance the research and development efforts at Lucence Life Sciences, fostering a dynamic environment for innovation.

Conclusion

Wai Jin Tan's contributions to the field of breast tumor diagnostics through his patented multigene assay represent a significant advancement in medical technology. His work not only aids in accurate tumor classification but also plays a crucial role in the management and treatment of patients with fibroepithelial tumors.